←
David van Duin5,195 posts
David van Duin avatar

David van Duin

@davidvanduin

Infectious Diseases doc with interests in multi-drug resistant Gram-negative bacteria, and transplant, hem/onc, and burn patients. Opinions are my own.

◷ Joined February 2014▧ 760 Photos and videos
IDWeek avatar
⟳ David van Duin retweeted
IDWeek@IDWeekmtg·7 Jul 2023

Whatever area of focus, whatever stage in your career, you belong here. Join your colleagues Oct. 11-15 in Boston for #IDWeek2023, the premier meeting for infectious diseases professionals. Register: idweek.org/registration

0:19
JAC-AMR avatar
⟳ David van Duin retweeted
JAC-AMR@jac_amr·13 Jul 2023

“Resistance of Acinetobacter baumannii to the recently available cefiderocol is concerning. Sulbactam/durlobactam is a promising option for MDR A. baumannii” Read the article by Tiseo et al: doi.org/10.1093/jacamr/dlad0… @OUPMedicine @OxfordJournals #JACNews

BSAC avatar
⟳ David van Duin retweeted
BSAC@BSACandJAC·13 Jul 2023

Kakooza et al. report high prevalence of resistance to ciprofloxacin, tetracycline and benzylpenicillin, and emerging resistance determinants for azithromycin, in gonococcal isolates from African countries: doi.org/10.1093/jac/dkad193 @OUPMedicine @OxfordJournals #JACNews

IDSA avatar
⟳ David van Duin retweeted
IDSA@IDSAInfo·11 Jul 2023

In 2019, an estimated 1.27 million deaths worldwide were directly caused by AMR, and AMR played a part in nearly 5 million deaths. US healthcare costs linked to infections from six of the biggest AMR threats total more than $4.6 billion annually,  with $1.9 billion of these costs borne by Medicare, says @hboucher3 to @GOPHELP and @HELPCmteDems.

Post attachment
IDWeek avatar
⟳ David van Duin retweeted
IDWeek@IDWeekmtg·11 Jul 2023

The deadline is fast approaching to submit your team for IDBugBowl, the Jeopardy-style quiz game you know and love. Get your team together and submit your application by July 28: bit.ly/44wmRIo

Post attachment
HMH Infectious Disease Fellowships avatar
⟳ David van Duin retweeted
HMH Infectious Disease Fellowships@HMH_IDfellow·11 Jul 2023

ID BOARD REVIEW 45 YO M from Vietnam moved to the US 20 yrs ago s/p kidney Tx on tacrolimus & prednisone, c/o sudden headache & neck stiffness. LP done & CSF has 2000 WBC’s/mm3 (70% neutrophils), glucose of 10 mg/dl & gram stain has GNB’s. CSF Cx + for E.coli. Empiric Rx is:

Adarsh Bhimraj MD FIDSA avatar
⟳ David van Duin retweeted
Adarsh Bhimraj MD FIDSA@adarsh_bhimraj·12 Jul 2023

Here is a brief twetorial on test taking strategies and how to approach a multiple choice question. New to posting twetorials & twitter threads, so would love feedback from Twitter gurus @PaulSaxMD @CarlosdelRio7 @davidvanduin @IDSAInfo

Test Taking Strategies for the Boards & In training exam (ITE). How to take multiple choice tests? Here's a twetorial on test-taking and preparing for boards and ITE's. #TestTaking #StudyTips @SuperBugDoc @IDSAMedEdCOP @swinndong @PaulSaxMD

Barabas group avatar
⟳ David van Duin retweeted
Barabas group@BarabasGroup·8 Jul 2023

We are looking for PhD candidates🎓 to join our ERC Grant about the spread of antibiotic resistance. Dive into structural biology, biochemistry and microbiology in University of Geneva🇨🇭with cutting edge equipment for cryo-EM/ET and a beautifully place to work! please RT🔁

Post attachment
Arturo Casadevall avatar
⟳ David van Duin retweeted
Arturo Casadevall@ACasadevall1·9 Jul 2023

Long ago, the field of ID could have carved out paid niches in the interpretation of cultures, susceptibilities, etc. (like other specialties do). However, none of that happened and today the specialty can't attract sufficient fellows because other fields are more lucrative.

Because, as @ACasadevall1 taught me years ago, decades ago the ID community failed to work with government and regulators to protect the special expertise unique to ID training. Other specialties were much more proactive in carving out their controlled expertise.

David van Duin avatar
David van Duin@davidvanduin·8 Jul 2023

Nice work by Dylan Brown (starting Med school at ⁦@HofstraU⁩ in fall👍👍): Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales | Infection Control & Hospital Epidemiology | Cambridge Core cambridge.org/core/journals/…

JAC-AMR avatar
⟳ David van Duin retweeted
JAC-AMR@jac_amr·30 Jun 2023

We’re pleased to share our latest impact metrics: JAC-AMR was recently awarded a CiteScore™ (Scopus) of 3.8 & our first Impact Factor (Journal Citation Reports™) of 3.4 Thanks to all our authors, reviewers & Editors! academic.oup.com/jacamr/page… @BSACandJAC @davidvanduin